Mitoxyperilysis——a Novel Pathway of Cell Death Connecting Dietary Interventions and Innate Immune Activation
- VernacularTitle:线粒体氧化膜裂解死亡——连接饮食干预和先天免疫激活的新型细胞死亡途径
- Author:
Yi WANG
1
;
Zhe CHEN
1
;
Xin LI
1
;
Lin-Xi CHEN
1
Author Information
- Publication Type:Journal Article
- Keywords: mitoxyperilysis; cell death; fasting; mTORC2; cancer therapy
- From: Progress in Biochemistry and Biophysics 2026;53(3):783-788
- CountryChina
- Language:Chinese
- Abstract: Dietary interventions such as fasting are gaining increasing attention for their synergistic effects in anti-tumor therapy, yet the precise underlying mechanisms remain incompletely understood. Recent research has unveiled a novel mode of cell death named “mitoxyperilysis”, providing a fresh perspective on the molecular mechanisms by which fasting may interfere with tumor treatment. This form of death is primarily triggered by the synergy between metabolic dysfunction and innate immune activation. Its mechanism involves the mTORC2 signaling pathway mediating prolonged abnormal contact between damaged mitochondria and the plasma membrane. This leads to massive local release of reactive oxygen species (ROS), which further induces lipid peroxidation of the plasma membrane, ultimately resulting in the physical rupture and death of the cell. The most significant distinction between mitoxyperilysis and classical cell death pathways lies in its independence from caspases and GSDMD. This comment aims to systematically elucidate the process, molecular mechanisms, and differences from other classical cell death pathways of mitoxyperilysis, while also exploring its potential for clinical translation in oncological diseases. Targeting induction of mitoxyperilysis may enhance the efficacy of existing anti-tumor drugs and overcome chemotherapy resistance. However, intervention protocols require further optimization to achieve an optimal balance between safety and therapeutic effectiveness in clinical application.
